History of Quincy Bioscience
Quincy Bioscience is a biotechnology company with its primary consumer product called Prevagen®, a dietary supplement designed to support brain health and to improve memory. Currently Prevagen is the No. 1 selling brain health supplement per Nielsen data in chain pharmacies in the United States including distribution in Walgreens, Rite Aid and CVS stores in addition to placement in several thousand independent health food stores and pharmacies.
The main focus of Quincy is the discovery, development and commercialization of novel technologies to support cognitive function and other age-related health challenges such as memory loss. Clinical data on Prevagen has demonstrated improvement in several areas of cognition in double-blinded and placebo-controlled human clinical trials. These trials have been published in peer-reviewed journals and presented at various international neuroscience conferences.
Quincy Bioscience’s first headquarters building was located in the University Research Park in Madison, Wis. in the fall of 2004. Simultaneously, a partnership was formed with the laboratory of Dr. James R. Moyer, Jr. of the University of Wisconsin at Milwaukee. Dr. Moyer is a leading expert in the field of calcium-mediated cellular mechanisms.
To accommodate growth in all areas of the organization, Quincy Bioscience moved out of the University Research Park in 2010 to its current location, which is four times larger than the previous office space and sufficient to accommodate growing staff and future needs.
In 2014, a regional office was established in Dallas, Texas.